Defining the human T helper 17 cell phenotype

Trends in Immunology

Volumn 33, Issue 10, 2012, Pages 505-512

  Annunziato, Francesco ^a   Cosmi, Lorenzo ^a   Liotta, Francesco ^a   Maggi, Enrico ^a   Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; DECTIN 2; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR TYPE I; INTERLEUKIN 5; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL EXPANSION; CELL LINEAGE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROCYTE SEDIMENTATION RATE; GENE DELETION; GENE OVEREXPRESSION; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CYTOKINES; HUMANS; MODELS, IMMUNOLOGICAL; PHENOTYPE; RECEPTORS, CYTOKINE; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84866749073     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.05.004     Document Type: Review

References (87)

1. Mosmann T.R., Coffman R.L. TH1 And TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
2. Romagnani S. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 1994, 12:227-257.
3. Harrington L.E., et al. Interleukin-17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 5:1123-1132.
4. Park H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 5:1133-1141.
5. Wilson N.J., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
6. Baba M., et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 1997, 272:14983-14988.
7. Hirota K., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 2007, 204:2803-2812.
8. Chizzolini, et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008, 112:3696-3703.
9. Pelletier M., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
10. Nurieva R., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory cells. Nature 2007, 448:480-483.
11. Korn T., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
12. Geri G., et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J. Allergy Clin. Immunol. 2011, 128:655-664.
13. Zhang Y., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
14. Eyerich S., et al. Th22 represent a distinct subset of human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 2009, 119:3573-3585.
15. Fickenscher H., Pirzer H. Interleukin-26. Int. Immunopharmacol. 2004, 4:609-613.
16. Darnbacher J., et al. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2009, 58:1207-1217.
17. Codarri L., et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
18. El-Behi M., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
19. Annunziato F., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
20. Kebir H., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
21. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
22. Cosmi L., et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 2010, 125:222-230.
23. Wang Y.-H., et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010, 207:2479-2491.
24. Zielinski C.E., et al. Pathogen-induced human T(H)17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012, 484:514-518.
25. Ivanov I.I., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
26. Rengarajan J., et al. Transcriptional regulation of TH1/TH2 polarization. Immunol. Today 2000, 21:479-483.
27. Yang X.O., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
28. Acosta Rodriguez E.V., et al. Surface phenotype and antigen specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
29. Manel N., et al. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008, 9:641-649.
30. Crome S.Q., et al. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Eur. J. Immunol. 2009, 39:1480-1493.
31. Yang X.O. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, 282:9358-9363.
32. Durant L., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010, 32:605-615.
33. Holland S.M., et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 2007, 357:1608-1619.
34. Milner J.D., et al. Impaired T(H) cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
35. Annunziato F., Romagnani S. The transient nature of the Th17 phenotype. Eur. J. Immunol. 2010, 40:3312-3316.
36. H17 lineage. Nature 2006, 441:231-234.
37. Veldohen M., Stockinger B. TGFβ1, a " Jack of all trades": the link with proinflammatory IL-17-producing T cells. Trends Immunol. 2006, 27:358-361.
38. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
39. Weaver C.T., et al. IL-17 family cytokines and the expanding diversity of effector T lymphocytes. Annu. Rev. Immunol. 2007, 25:821-852.
40. Doenick E.K., et al. Autoimmunity: IL-21: a new player in Th17-cell differentiation. Immunol. Cell Biol. 2007, 86:478.
41. Acosta-Rodriguez E.V., et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
42. H-17 responses. Nat. Immunol. 2008, 9:650-657.
43. Yang, L. et al. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 454, 350-352.
44. Cosmi L., et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 2008, 205:1903-1916.
45. Santarlasci V., et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 2010, 40:207-215.
46. Veldohen M., et al. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
47. Sutton C., et al. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
48. Chung Y., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
49. Shaw M.H., et al. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J. Exp. Med. 2012, 209:251-258.
50. Annunziato F., Romagnani S. Do studies in humans better depict Th17 cells?. Blood 2009, 115:2213-2219.
51. Ghoreschi K., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010, 467:967-971.
52. Das J., et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 differentiation. J. Exp. Med. 2009, 206:2407-2416.
53. Marks B.R., et al. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009, 10:1125-1132.
54. Kim J.S., et al. The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J. Exp. Med. 2011, 208:2201-2207.
55. Lanier L., et al. Human NKR-P1A. A disulphide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 1994, 153:2417-2428.
56. Fogal B., et al. Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+CD4+ regulatory T cells. J. Immunol. 2011, 187:6268-6280.
57. Schleinceck M.A., et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009, 296:525-534.
58. Cosmi L., et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011, 63:2504-2515.
59. Wei G., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
60. Lexberg M.H., et al. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 2008, 38:2654-2664.
61. Bending D., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009, 119:565-572.
62. Hirota K., et al. Fate mapping of interleukin 17-producing T cells in inflammatory responses. Nat. Immunol. 2011, 12:255-263.
63. Lee Y.K., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
64. Boniface K., et al. Human Th17 cells comprise heterogenous subsets including IFN-γ-producing cells with distinct properties from the Th1 lineage. J. Immunol. 2010, 185:679-687.
65. Hoechst B., et al. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2012, 117:6532-6541.
66. Cohen C.J., et al. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J. Immunol. 2011, 187:5615-5626.
67. Brucklander-Waldert V., et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341.
68. Annunziato F., et al. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int. Immunol. 2008, 20:1361-1368.
69. Maggi L., et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 2010, 67:726-738.
70. Poggi A., et al. Phenotypic and functional analysis of CD4+ NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration. Eur. J. Immunol. 1997, 27:2345-2350.
71. Bezouska K., et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994, 372:150-157.
72. Ishihara S., et al. CD8+NKR-PIA+ T cells preferentially accumulate in human liver. Eur. J. Immunol. 1999, 29:2406-2413.
73. Plougastel B., et al. Cloning of Clr, a new family of lectin-like genes localized between mouse Nksp1a and CD69. Immunogenetics 2001, 53:209-214.
74. Carlyle J.R., et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3527-3532.
75. Ademir H., et al. Lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 2005, 175:7791-7795.
76. Rosen D.B., et al. Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 2005, 180:6508-6517.
77. Huarte E., et al. PILAR is a novel modulator of human T-cell expansion. Blood 2008, 112:1259-1268.
78. Fergusson J.R., et al. CD161-expressing human T cells. Front. Immunol. 2011, 2:1-7.
79. Santarlasci V., et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012, 36:201-214.
80. Chu C.C., Paul W.E. Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis. Mol. Immunol. 1998, 35:487-502.
81. Boulland M.L., et al. Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood 2007, 110:220-227.
82. Oh H.M., et al. STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors. J. Biol. Chem. 2011, 286:30888-30897.
83. Fabre S., et al. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J. Immunol. 2005, 174:4161-4171.
84. Peng S.L. Foxo in the immune system. Oncogene 2008, 27:2337-2344.
85. Paulos C.M., et al. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci. Transl. Med. 2010, 2:55ra78.
86. de Wit J., et al. CD5 costimulation induces stable TH17 development by promoting IL-23R expression and sustained STAT3 activation. Immunobiology 2011, 118:6107-6114.
87. Montaldo E., et al. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood 2012, 119:3987-3996.